Type 2 Diabetes Glycosylated Hemoglobin Targets: ACP Guidance Statement

Reviewers for the American College of Physicians integrate HbA_1c target recommendations from multiple guidelines that have been published since 2013.

Sponsoring Organization: American College of Physicians (ACP)

Target Audience: Primary care clinicians, endocrinologists, and hospitalists

Background

Reviewers for the ACP have critically evaluated six recently published guidelines — from the Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE), the American Diabetes Association (ADA), the Institute for Clinical Systems Improvement (ICSI), the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN), and the U.S. Department of Veterans Affairs and Department of Defense (VA/DoD). They offer summary guidance in using glycosylated hemoglobin (HbA_1c) targets in managing nonpregnant adults with type 2 diabe…

Reviewing Author

Daniel D. Dressler, MD, MSc, SFHM, FACP

Disclosures

RoyaltiesMcGraw-Hill; Elsevier

Editorial BoardsMedical Clinics of North America; Caribbean Medical Journal International Advisory Panel (2021–2026)

Daniel D. Dressler, MD, MSc, SFHM, FACP

Disclosures

RoyaltiesMcGraw-Hill; Elsevier

Editorial BoardsMedical Clinics of North America; Caribbean Medical Journal International Advisory Panel (2021–2026)

Type 2 Diabetes Glycosylated Hemoglobin Targets: ACP Guidance Statement

Topics

Background

Reviewing Author